Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1012456 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Christopher T Edwards und 33 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Spike Glycoprotein, Coronavirus, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIH HHS, Gates Foundation, NIAID NIH HHS.
Abstract (Originalsprache)
The continued evolution of SARS-CoV-2 variants capable of subverting vaccine and infection-induced immunity suggests the advantage of a broadly protective vaccine against betacoronaviruses (β-CoVs). Recent studies have isolated monoclonal antibodies (mAbs) from SARS-CoV-2 recovered-vaccinated donors capable of neutralizing many variants of SARS-CoV-2 and other β-CoVs. Many of these mAbs target the conserved S2 stem region of the SARS-CoV-2 spike protein, rather than the receptor binding domain contained within S1 primarily targeted by current SARS-CoV-2 vaccines. One of these S2-directed mAbs, CC40.8, has demonstrated protective efficacy in small animal models against SARS-CoV-2 challenge. As the next step in the pre-clinical testing of S2-directed antibodies as a strategy to protect from SARS-CoV-2 infection, we evaluated the in vivo efficacy of CC40.8 in a clinically relevant non-human primate model by conducting passive antibody transfer to rhesus macaques (RM) followed by SARS-CoV-2 challenge. CC40.8 mAb was intravenously infused at 10mg/kg, 1mg/kg, or 0.1 mg/kg into groups (n = 6) of RM, alongside one group that received a control antibody (PGT121). Viral loads in the lower airway were significantly reduced in animals receiving higher doses of CC40.8. We observed a significant reduction in inflammatory cytokines and macrophages within the lower airway of animals infused with 10mg/kg and 1mg/kg doses of CC40.8. Viral genome sequencing demonstrated a lack of escape mutations in the CC40.8 epitope. Collectively, these data demonstrate the protective efficiency of broadly neutralizing S2-targeting antibodies against SARS-CoV-2 infection within the lower airway while providing critical preclinical work necessary for the development of pan–β-CoV vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
- Department of Pathology, Microbiology & Immunology, Vanderbilt University, Nashville, Tennessee, United States of America.
- Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
- Mayo Clinic Medical Scientist Training Program, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, United States of America.
- Vaccine Research Center; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
- Tulane National Primate Research Center, Covington, Los Angeles, United States of America.
ORCID-Profile: Steven E Bosinger
Förderung
- NIH HHS
- Gates Foundation
- NIAID NIH HHS
- Bill and Melinda Gates Foundation
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Edwards, C. T., Karunakaran, K. A., Garcia, E., Beutler, N., Gagne, M., Golden, N., Aoued, H., Pellegrini, K. L., Burnett, M. R., Honeycutt, C. C., Lapp, S. A., Ton, T., Lin, M. C., Metz, A., Bombin, A., Goff, K., Scheuermann, S. E., Wilkes, A., Wood, J. S., …, & Bosinger, S. E. (2025). Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012456
Vancouver
Edwards CT, Karunakaran KA, Garcia E, Beutler N, Gagne M, Golden N, et al. Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1012456
BibTeX
@article{Edwards2025,
author = {Edwards, Christopher T and Karunakaran, Kirti A and Garcia, Elijah and Beutler, Nathan and Gagne, Matthew and Golden, Nadia and Aoued, Hadj and Pellegrini, Kathryn L and Burnett, Matthew R and Honeycutt, Christopher Cole and Lapp, Stacey A and Ton, Thang and Lin, Mark C and Metz, Amanda and Bombin, Andrei and Goff, Kelly and Scheuermann, Sarah E and Wilkes, Amelia and Wood, Jennifer S and Ehnert, Stephanie and Weissman, Stacey and Curran, Elizabeth H and Roy, Melissa and Dessasau, Evan and Paiardini, Mirko and Upadhyay, Amit A and Moore, Ian N and Maness, Nicholas J and Douek, Daniel C and Piantadosi, Anne and Andrabi, Raiees and Rogers, Thomas R and Burton, Dennis R and Bosinger, Steven E},
title = {Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1012456}
}
EUVIMED